Literature DB >> 15486209

Osteoporotic vertebral collapse: percutaneous vertebroplasty and local kyphosis correction.

Robert Y Carlier1, Haleh Gordji, Dominique M Mompoint, Nicolas Vernhet, Antoine Feydy, Christian Vallée.   

Abstract

Forty-six cases of osteoporotic vertebral collapse (27 thoracic, 19 lumbar) were treated by means of percutaneous vertebroplasty in a hyperlordosis position. Institutional review board approval and informed consent were obtained. Kyphosis reducibility was preprocedurally estimated from the angular difference between neutral and hyperlordosis positions. Effective reduction was the angular difference in neutral positions before and after vertebroplasty. Reduction (< or =14 degrees ; mean, 6.43 degrees) was obtained in cases with estimated reducibility greater than 5 degrees (31 cases, 67%), which is a 34% (6.5 degrees of 19.1 degrees ) mean reduction. A significantly greater level of kyphosis reduction was observed in cases with intravertebral clefts (20 cases, 43%) at hyperlordosis than in those without (7.2 degrees vs 4.9 degrees ; P < .01). Vertebroplasty may reduce kyphosis due to localized collapsed vertebrae; intravertebral mobility and cleft suggest this possibility. (c) RSNA, 2004.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486209     DOI: 10.1148/radiol.2333030400

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  Kyphoplasty: an assessment of a new technology.

Authors:  H J Cloft; M E Jensen
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

Review 2.  Percutaneous Vertebral Augmentation Techniques in Osteoporotic and Traumatic Fractures.

Authors:  Valérie Bousson; Bassam Hamze; Guillaume Odri; Thomas Funck-Brentano; Philippe Orcel; Jean-Denis Laredo
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

3.  Radiological findings as favorable predictors of pain relief in patients with osteoporotic compression fractures after percutaneous vertebroplasty: a retrospective study of 156 cases.

Authors:  Masakazu Hirakawa; Nobuo Kobayashi; Mitsutomi Ishiyama; Sokun Fuwa; Yukihisa Saida; Hiroshi Honda; Yuji Numaguchi
Journal:  Jpn J Radiol       Date:  2012-02-28       Impact factor: 2.374

Review 4.  Comparative review of vertebroplasty and kyphoplasty.

Authors:  Fernando Ruiz Santiago; Alicia Santiago Chinchilla; Luis Guzmán Álvarez; Antonio Luis Pérez Abela; Maria Del Mar Castellano García; Miguel Pajares López
Journal:  World J Radiol       Date:  2014-06-28

5.  Percutaneous vertebroplasty for intravertebral cleft: analysis of therapeutic effects and outcome predictors.

Authors:  Yeo Ju Kim; Joon Woo Lee; Ki-Jeong Kim; Sang-Ki Chung; Hyun-Jib Kim; Jeong Mi Park; Heung Sik Kang
Journal:  Skeletal Radiol       Date:  2010-02-09       Impact factor: 2.199

6.  Height restoration and wedge angle correction effects of percutaneous vertebroplasty: association with intraosseous clefts.

Authors:  Gang Sun; Peng Jin; Min Li; Xun-Wei Liu; Fan-Dong Li
Journal:  Eur Radiol       Date:  2011-08-07       Impact factor: 5.315

7.  Vertebroplasty in the treatment of spine disease.

Authors:  G Ambrosanio; A Lavanga; P Vassallo; R Izzo; A A Diano; M Muto
Journal:  Interv Neuroradiol       Date:  2006-02-10       Impact factor: 1.610

8.  Vertebral body stenting: a new method for vertebral augmentation versus kyphoplasty.

Authors:  Robert Rotter; Heiner Martin; Sebastian Fuerderer; Michael Gabl; Christoph Roeder; Paul Heini; Thomas Mittlmeier
Journal:  Eur Spine J       Date:  2010-03-01       Impact factor: 3.134

9.  New symptomatic compression fracture after percutaneous vertebroplasty at the thoracolumbar junction.

Authors:  C C Lin; I H Chen; T C Yu; A Chen; P S Yen
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

10.  Evaluation of a novel radiopacifiying agent on the physical properties of surgical spineplex.

Authors:  D O'Brien; D Boyd; S Madigan; S Murphy
Journal:  J Mater Sci Mater Med       Date:  2009-08-18       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.